Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
DNA Damage can Stall the Cell Cycle02:37

DNA Damage can Stall the Cell Cycle

9.1K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.1K
Epigenetic Regulation01:37

Epigenetic Regulation

3.0K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.0K
Negative Regulator Molecules01:23

Negative Regulator Molecules

35.2K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.2K
RNA Stability01:53

RNA Stability

33.4K
Intact DNA strands can be found in fossils, while scientists sometimes struggle to keep RNA intact under laboratory conditions. The structural variations between RNA and DNA underlie the differences in their stability and longevity. Because DNA is double-stranded, it is inherently more stable. The single-stranded structure of RNA is less stable but also more flexible and can form weak internal bonds. Additionally, most RNAs in the cell are relatively short, while DNA can be up to 250 million...
33.4K
MicroRNAs01:22

MicroRNAs

21.2K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Magrolimab Plus Azacitidine Versus Placebo Plus Azacitidine in Patients With Untreated Higher-Risk Myelodysplastic Syndromes: The Phase III ENHANCE Study.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

Durable response to salvage gilteritinib, allogeneic stem cell rescue and maintenance therapy in relapsed AML with a <i>FLT3</i> N676K variant.

Leukemia & lymphoma·2026
Same author

Real-world, multi-omics validation of the clinical relevance of molecular taxonomy for myelodysplastic syndromes (MDS).

HemaSphere·2026
Same author

ELN-DAVID Recommendations for NGS-based FLT3-ITD MRD Testing in Patients with Acute Myeloid Leukemia.

Blood·2026
Same author

The roles of the acetyltransferase domains of the chromatin regulators KAT6A and KAT6B in vivo.

Development (Cambridge, England)·2026
Same author

Olutasidenib as maintenance therapy after treatment response in acute myeloid leukemia with persistent <i>IDH1</i> mutation.

Blood neoplasia·2026

Related Experiment Video

Updated: Jun 14, 2025

Yeast As a Chassis for Developing Functional Assays to Study Human P53
14:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

9.5K

Transcriptomic changes including p53 dysregulation prime DNMT3A mutant cells for transformation.

Erin M Lawrence1,2, Amali Cooray1,2, Andrew J Kueh1,2,3,4

  • 1Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia.

EMBO Reports
|April 30, 2025
PubMed
Summary

DNMT3A mutations accelerate lymphoma development in mice by impairing DNA methylation and p53 signaling in hematopoietic stem cells. This leads to increased self-renewal and a higher risk of malignant transformation.

Keywords:
DNA MethylationDNMT3AEpigeneticsGenetic EngineeringHaematological Cancers

More Related Videos

Immunostaining for DNA Modifications: Computational Analysis of Confocal Images
09:42

Immunostaining for DNA Modifications: Computational Analysis of Confocal Images

Published on: September 7, 2017

9.7K
Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors
06:07

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors

Published on: August 5, 2022

2.5K

Related Experiment Videos

Last Updated: Jun 14, 2025

Yeast As a Chassis for Developing Functional Assays to Study Human P53
14:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

9.5K
Immunostaining for DNA Modifications: Computational Analysis of Confocal Images
09:42

Immunostaining for DNA Modifications: Computational Analysis of Confocal Images

Published on: September 7, 2017

9.7K
Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors
06:07

Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors

Published on: August 5, 2022

2.5K

Area of Science:

  • Genetics
  • Cancer Biology
  • Epigenetics

Background:

  • DNA methyltransferase 3A (DNMT3A) mutations are common in blood cancers.
  • The R882H mutation in DNMT3A is a known 'hotspot' in human malignancies.
  • Understanding the functional impact of DNMT3A mutations is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the functional consequences of a DNMT3A mutation (R878H) in a mouse model.
  • To explore the role of DNMT3A mutations in hematopoietic stem/progenitor cell (HSPC) behavior and radiation sensitivity.
  • To elucidate the molecular mechanisms underlying DNMT3A-driven leukemogenesis.

Main Methods:

  • Generated a mouse model with a heterozygous R878H mutation in the Dnmt3a gene.
  • Performed competitive transplantation assays with Lin-Sca-1+Kit+ (LSK) HSPCs.
  • Utilized RNA sequencing to analyze gene expression changes in irradiated LSK cells.
  • Assessed p53 pathway activation and PUMA expression via flow cytometry.

Main Results:

  • The R878H mutation led to global DNA hypomethylation and accelerated thymic lymphoma development after gamma-radiation exposure.
  • Dnmt3aR878H/+ LSK HSPCs exhibited enhanced self-renewal capacity over wild-type counterparts.
  • Irradiated Dnmt3aR878H/+ LSK cells showed p53 pathway downregulation and reduced PUMA expression.
  • Impaired p53 signaling was confirmed in the bone marrow of irradiated mutant mice.

Conclusions:

  • DNMT3A R878H mutations confer a competitive advantage to HSPCs, promoting self-renewal at the expense of differentiation.
  • These mutations sensitize cells to genotoxic stress by impairing the p53 response.
  • Subtle transcriptomic alterations in LSK cells driven by DNMT3A mutations contribute to leukemogenesis.